GLP - 1 Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting glp - 1 clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3. Top locations include Bergen, Vestland, Norway, Cary, North Carolina, United States, Charlottesville, Virginia, United States. Updated daily from ClinicalTrials.gov.


GLP - 1 Trials at a Glance

13 actively recruiting trials for glp - 1 are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bergen, Cary, and Charlottesville. Lead sponsors running glp - 1 studies include Athletic Greens International, Attikon Hospital, and AgelessRx.

Browse glp - 1 trials by phase

Treatments under study

About GLP - 1 Clinical Trials

Looking for clinical trials for GLP - 1? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new GLP - 1 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about GLP - 1 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Dry Eye Disease (DED)Diabetes Type 2Diabete Mellitus+3 more
Attikon Hospital100 enrolled1 locationNCT07605572
Recruiting
Not Applicable

Slowly Digestible Carbohydrates for GLP-1 Secretion

Blood GlucoseGLP - 1Satiety+2 more
Purdue University19 enrolled1 locationNCT07572513
Recruiting
Phase 2

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Obesity in childrenObesityLifestyle Modification+3 more
University of Virginia120 enrolled1 locationNCT06903923
Recruiting

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

ObesityDiabetesType 2 Diabetes+2 more
University of Alberta50 enrolled1 locationNCT07272837
Recruiting
Phase 2

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Weight LossObesity PreventionSarcopenia in Elderly+2 more
The University of Texas Health Science Center at San Antonio20 enrolled1 locationNCT06811324
Recruiting
Phase 4

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

ObesityWeight LossBipolar I Disorder+3 more
Mayo Clinic100 enrolled1 locationNCT07213466
Recruiting
Not Applicable

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs

nutrition statusGastrointestinal MicrobiomeGLP - 1+1 more
Athletic Greens International120 enrolled1 locationNCT07437911
Recruiting

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

Body CompositionMuscle FunctionGLP - 1+1 more
University of Kansas Medical Center50 enrolled1 locationNCT07422987
Recruiting
Phase 4

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Bowel preparation for colonoscopyGLP - 1
The Cleveland Clinic132 enrolled3 locationsNCT07127354
Recruiting

The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight

NutritionGLP - 1
Medical University of Warsaw100 enrolled1 locationNCT07270497
Recruiting

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Eating DisordersBinge-Eating DisorderCBT+4 more
Haukeland University Hospital80 enrolled1 locationNCT07042672
Recruiting
Phase 2Phase 3

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

longevityAgingGLP - 1+1 more
AgelessRx150 enrolled1 locationNCT07092618
Recruiting
Not Applicable

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Obesity and OverweightObesity PreventionObesity and Obesity-related Medical Conditions+3 more
Dr. Christopher McGowan20 enrolled2 locationsNCT06734312